Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease - PubMed (original) (raw)

Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease

E A Grace et al. Neuroscience. 2002.

Abstract

Amyloid deposition, neuronal dystrophy and synaptic loss are characteristic pathological features of Alzheimer's disease (AD). We have used cortical neuronal cultures to assess the dystrophic effect of fibrillar amyloid beta (Abeta) and its relationship with neurotoxicity and synaptic loss. Treatment with fibrillar Abeta led to the development of neuritic dystrophy in the majority of the neurons present in the culture. Morphometric analysis and viability assays showed that neuronal dystrophy appeared significantly earlier and at lower Abeta concentrations than neurotoxicity, suggesting that both effects are generated independently by different cellular mechanisms. The development of dystrophic features required Abeta fibril formation and did not depend on the presence of the RHDS adhesive domain in the sequence of Abeta. Finally, a dramatic reduction in the density of synaptophysin immunoreactivity was closely associated with dystrophic changes in viable neurons. These results suggest that aberrant plastic changes and loss of synaptic integrity induced by fibrillar Abeta may play a significant role in the development of AD pathology.

PubMed Disclaimer

Cited by

Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease.
Heredia L, Helguera P, de Olmos S, Kedikian G, Solá Vigo F, LaFerla F, Staufenbiel M, de Olmos J, Busciglio J, Cáceres A, Lorenzo A. Heredia L, et al. J Neurosci. 2006 Jun 14;26(24):6533-42. doi: 10.1523/JNEUROSCI.5567-05.2006. J Neurosci. 2006. PMID: 16775141 Free PMC article.
Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease.
Maloney MT, Minamide LS, Kinley AW, Boyle JA, Bamburg JR. Maloney MT, et al. J Neurosci. 2005 Dec 7;25(49):11313-21. doi: 10.1523/JNEUROSCI.3711-05.2005. J Neurosci. 2005. PMID: 16339026 Free PMC article.
beta-Amyloid and endoplasmic reticulum stress responses in primary neurons: effects of drugs that interact with the cytoskeleton.
Seyb KI, Ansar S, Bean J, Michaelis ML. Seyb KI, et al. J Mol Neurosci. 2006;28(2):111-23. doi: 10.1385/jmn:28:2:111. J Mol Neurosci. 2006. PMID: 16679552
Neuritic regeneration and synaptic reconstruction induced by withanolide A.
Kuboyama T, Tohda C, Komatsu K. Kuboyama T, et al. Br J Pharmacol. 2005 Apr;144(7):961-71. doi: 10.1038/sj.bjp.0706122. Br J Pharmacol. 2005. PMID: 15711595 Free PMC article.
Sphingosine kinase-1 protects differentiated N2a cells against beta-amyloid25-35-induced neurotoxicity via the mitochondrial pathway.
Yang Y, Wang M, Lv B, Ma R, Hu J, Dun Y, Sun S, Li G. Yang Y, et al. Neurochem Res. 2014 May;39(5):932-40. doi: 10.1007/s11064-014-1290-6. Epub 2014 Mar 30. Neurochem Res. 2014. PMID: 24682752

Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease - PubMed (original) (raw)